Alexion Pharmaceuticals Aktie
WKN: 899527 / ISIN: US0153511094
16.02.2017 12:42:15
|
Alexion Expands Share Buyback; Sees FY17 Results Below View
(RTTNews) - Alexion Pharmaceuticals Inc. (ALXN) announced that its Board of Directors has increased the size of the Company's share repurchase authorization to a total of $1 billion.
For 2017, the company expects earnings per share to be in the range of $2.55 to $3.05, non-GAAP earnings per share of $5.00 to $5.25, and total revenues of $3.40 billion to $3.500 billion. Analysts polled by Thomson Reuters expect the company to report earnings of $5.54 per share and revenues of $3.54 billion. Analysts' estimates typically exclude special items.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Alexion Pharmaceuticals Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |